These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37569807)

  • 1. Inhibition of miR-25 Ameliorates Cardiac Dysfunction and Fibrosis by Restoring Krüppel-like Factor 4 Expression.
    Lee C; Cho S; Jeong D
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.
    Zhan H; Huang F; Niu Q; Jiao M; Han X; Zhang K; Ma W; Mi S; Guo S; Zhao Z
    Oxid Med Cell Longev; 2021; 2021():8889195. PubMed ID: 34646427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451a attenuates angiotensin II-induced cardiac fibrosis and inflammation by directly targeting T-box1.
    Deng HY; He ZY; Dong ZC; Zhang YL; Han X; Li HH
    J Physiol Biochem; 2022 Feb; 78(1):257-269. PubMed ID: 34851490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
    Gu J; Qiu M; Lu Y; Ji Y; Qian Z; Sun W
    Phytomedicine; 2021 Feb; 82():153461. PubMed ID: 33497927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
    Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
    Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
    Yoshida T; Yamashita M; Horimai C; Hayashi M
    J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
    Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p.
    Ni H; Li W; Zhuge Y; Xu S; Wang Y; Chen Y; Shen G; Wang F
    Int J Cardiol; 2019 Oct; 292():188-196. PubMed ID: 30967276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
    Ye B; Zhou H; Chen Y; Luo W; Lin W; Zhao Y; Han J; Han X; Huang W; Wu G; Wang X; Liang G
    Circ Res; 2023 Feb; 132(4):465-480. PubMed ID: 36722348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.
    Wang Q; Yu X; Dou L; Huang X; Zhu K; Guo J; Yan M; Wang S; Man Y; Tang W; Shen T; Li J
    Oxid Med Cell Longev; 2019; 2019():8768164. PubMed ID: 31612078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
    Ji H; Qu J; Peng W; Yang L
    Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
    Ge W; Hou C; Zhang W; Guo X; Gao P; Song X; Gao R; Liu Y; Guo W; Li B; Zhao H; Wang J
    J Mol Cell Cardiol; 2021 Mar; 152():52-68. PubMed ID: 33301800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling.
    Xia W; Zou C; Chen H; Xie C; Hou M
    Cell Death Dis; 2020 Jul; 11(7):575. PubMed ID: 32709878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis.
    Li L; Bounds KR; Chatterjee P; Gupta S
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29114000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.